Following the two consecutive boards, this pharmaceutical stock has opened the limit again!

【Pharmaceutical Network Pharmaceutical Stock Market】Following the 2 consecutive boards, on October 11, Huangshan capsules opened the limit again, as of 10:18 minutes, the stock was quoted 9.
65 yuan, an increase of 6.
16%, the turnover was 508 million, and the turnover rate was 18.
01%.
The stock is a hollow hard capsule manufacturer with more than 20 years of professional production experience, the company's main business is gelatin hollow capsules and enteric gelatin hollow capsules research and development, production and sales
.
The business scope of its subsidiary, Anhui DeRong Pharmaceutical Equipment Co.
, Ltd.
, is the research and development, production and sales of medical equipment, pharmaceutical equipment and capsule special equipment; Medical device sales
.
The analysis believes that the reason for the rise and stop of Huangshan Capsule is the transfer of shares + medical devices
.
On the news side, on the evening of September 29, Huangshan Capsule disclosed an indicative announcement
of a proposed change of control and change of interests.
The actual controllers of the Company, Yu Chunming and Yu Chaobiao, have signed the Share Transfer Agreement on Anhui Huangshan Capsule Co.
, Ltd.
with Shandong Lutai Holding Group Co.
, Ltd.
on September 29, 2022, and after the completion of this transaction, the control of the Company will be changed
.
Judging from the news of the medical device industry, on September 27, the centralized procurement of orthopedic spine consumables in the national tissue was better than expected
.
A total of 173 reporting enterprises were involved in this collection, and finally 152 enterprises were to be selected, with an average reduction of 84% for the products to be selected, and it is expected to save 26 billion yuan
.
After the end of the bidding, many companies participating in the collection and procurement reported that the results were better than their expectations
.
On the 27th, A-shares, Hong Kong orthopedic plates also rose online, as of the close, Weigao Orthopedics, iKang Medical, Sanyou Medical, Dabo Medical rose more than 10%, Kelly Tai, minimally invasive medical, Chunli medical followed suit
.
In addition, the Health Commission recently issued a notice that it intends to use financial discount loans to update and transform medical equipment, and intends to issue supporting policies in the near future to further clarify the policy
of using financial discount loans to update and transform medical equipment in hospitals.
According to the notice of the National Health Commission, the policy mainly involves the procurement and upgrading of medical equipment, mainly for domestic equipment
.
According to public data, there are nearly 950,000 primary medical and health institutions in China, and the release of the notice at this time will mean that primary medical institutions will usher in a wave of
equipment allocation.
Kaiyuan Securities Research Report pointed out that after the release of the notice, all provinces and cities have actively responded to the policy, and have begun to implement the investigation of the use of financial discount loans to update the demand for medical equipment, and only Zhejiang, Jiangsu and Anhui provinces have reported about 18 billion yuan of equipment procurement needs, which can be inferred that the national demand for hundreds of billions of medical equipment renovation is about to be released
.
Affected by industry news, the medical device sector has ushered in the first trading day of A shares after the National Day
.
A number of individual stocks, including Huangshan Capsules, once appeared on the list of gainers, and there were also Lianying Medical, Kaili Medical, and Aohua Endoscopic Endoscopy hitting a record high
.
Affected by the change in the transaction, Huangshan Capsule issued an announcement on the evening of October 10 that the closing price increase of Anhui Huangshan Capsule Co.
, Ltd.
on September 29, September 30 and October 9, 2022 exceeded 20%
in three consecutive trading days.
After verification, the company, the controlling shareholder and the actual controller have no material matters about the company that should be disclosed but have not been disclosed, or material matters
that are in the planning stage.
Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.